Southern Eye Specialists

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Macular degeneration4 trials
• Diabetic eye disease1 trial

Phase

• Phase 33 trials
• Phase 11 trial
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Annexon, Inc.1 trial
• Apellis Pharmaceuticals, Inc.1 trial
• ONL Therapeutics1 trial
• Ripple Therapeutics Pty Ltd1 trial
• Stealth BioTherapeutics Inc.1 trial

Running trials

• Active, not recruiting

  A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

  NCT06510816· Phase 3· Annexon, Inc.· Source

• Active, not recruiting

  ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

  NCT06373731· Phase 3· Stealth BioTherapeutics Inc.· Source

Closed trials

• Completed

  ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration

  NCT04744662· Phase 1· ONL Therapeutics· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source

• Completed

  Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy

  NCT04576689· Phase 2· Ripple Therapeutics Pty Ltd· Source